Advertisement

The inhibition of lamellar hydroxyapatite and lamellar magnetic hydroxyapatite on the migration and adhesion of breast cancer cells

  • Jun Jin
  • Guifu Zuo
  • Guangyao Xiong
  • Honglin Luo
  • Qiuping Li
  • Chunying Ma
  • Deying Li
  • Feng Gu
  • Yongjie Ma
  • Yizao WanEmail author
Article

Abstract

Hydroxyapatite nanoparticles have been reported to exhibit potent anti-tumor effects in some cancer cells. In our previous study, we have successfully synthesized two types of hydroxyapatite nanoparticles, laminated hydroxyapatite (L-HAp) and laminated magnetic hydroxyapatite (LM-HAp). In this study, we wanted to investigate the effects of L-HAp and LM-HAp with various concentrations on human breast cancer MDA-MB-231 cells. Cell proliferation was assessed with a MTT colorimetric assay. Scratch and adhesion assays were used to detect the effects of these two materials on migration and adhesion. The expressions of integrin β1 and Akt were measured by Western blotting. Our results showed that L-HAp and LM-HAp had little cell cytotoxicity and significantly reduced cell mobility and adhesion. LM-HAp showed greater inhibitor ability on migration and adhesion of MDA-MB-231 cells. Moreover, results from western blotting showed that L-HAp and LM-HAp impacted the phosphorylation of integrin β1, but showed no regular impact on Akt. This study suggests that L-HAp and LM-HAp may be potential anti-tumor and delivery system for breast cancer therapy.

Keywords

Breast Cancer Cell Hydroxyapatite Fe3O4 Nanoparticles Adhesion Assay Gene Delivery System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work is supported by the National Natural Science Foundation of China (Grants No. 51172158 and 81200663), the Science and Technology Support Program of Tianjin (Grant No. 11ZCKFSY01700) and the Natural Science Foundation of Hebei Province (Grants No. E2014209204).

References

  1. 1.
    Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127:679–95.CrossRefGoogle Scholar
  2. 2.
    Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998;153:333–9.CrossRefGoogle Scholar
  3. 3.
    Du C, Cui FZ, Zhu XD, de Groot K. Three-dimensional nano-HAp/collagen matrix loading with osteogenic cells in organ culture. J Biomed Mater Res. 1999;44:407–15.CrossRefGoogle Scholar
  4. 4.
    Wan YZ, Hong L, Jia SR, Huang Y, Zhu Y, Wang YL, et al. Synthesis and characterization of hydroxyapatite-bacterial cellulose nanocomposites. Compos Sci Technol. 2006;66:1825–32.CrossRefGoogle Scholar
  5. 5.
    Wei GB, Ma PX. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials. 2004;25:4749–57.CrossRefGoogle Scholar
  6. 6.
    Zhang RY, Ma PX. Poly(alpha-hydroxyl acids) hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res. 1999;44:446–55.CrossRefGoogle Scholar
  7. 7.
    Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusunose T, Toyonaga T, et al. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials. 2004;25:3807–12.CrossRefGoogle Scholar
  8. 8.
    Palazzo B, Iafisco M, Laforgia M, Margiotta N, Natile G, Bianchi CL, et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater. 2007;17:2180–8.CrossRefGoogle Scholar
  9. 9.
    Yang P, Quan Z, Li C, Kang X, Lian H, Lin J. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. Biomaterials. 2008;29:4341–7.CrossRefGoogle Scholar
  10. 10.
    Wu GJ, Zhou LZ, Wang KW, Chen F, Sun Y, Duan YR, et al. Hydroxylapatite nanorods: an efficient and promising carrier for gene transfection. J Colloid Interface Sci. 2010;345:427–32.CrossRefGoogle Scholar
  11. 11.
    Meena R, Kesari KK, Rani M, Paulraj R. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human breast cancer cells (MCF-7). J Nanopart Res. 2012;14:712.CrossRefGoogle Scholar
  12. 12.
    Chen X, Deng C, Tang S, Zhang M. Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells. Biol Pharm Bull. 2007;30:128–32.CrossRefGoogle Scholar
  13. 13.
    Liu ZS, Tang SL, Ai ZL. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World J Gastroenterol. 2003;9:1968–71.Google Scholar
  14. 14.
    Zuo GF, Wan YZ, Meng XG, Zhao Q, Ren K, Jia S, et al. Synthesis and characterization of a lamellar hydroxyapatite/DNA nanohybrid. Mater Chem Phys. 2011;126:470–5.CrossRefGoogle Scholar
  15. 15.
    Zuo GF, Wan YZ, Zhang Y. Preparation and characterization of a novel laminated magnetic hydroxyapatite for application on gene delivery. Mater Lett. 2012;68:225–7.CrossRefGoogle Scholar
  16. 16.
    Kaczarek E, Zapf S, Bouterfa H, Tonn JC, Westphal M, Giese A. Dissecting glioma invasion: interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype. Int J Dev Neurosci. 1999;17:625–41.CrossRefGoogle Scholar
  17. 17.
    Doerr ME, Jones JI. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem. 1996;271:2443–7.CrossRefGoogle Scholar
  18. 18.
    Yuan Y, Liu C, Qian J, Wang J, Zhang Y. Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials. 2010;31:730–40.CrossRefGoogle Scholar
  19. 19.
    Ananthakrishnan R, Ehrlicher A. The forces behind cell movement. Int J Biol Sci. 2007;3:303–17.CrossRefGoogle Scholar
  20. 20.
    Collective Rorth P, Migration Cell. Annu Rev Cell Dev Biol. 2009;25:407–29.CrossRefGoogle Scholar
  21. 21.
    Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol. 2005;23:2411–22.CrossRefGoogle Scholar
  22. 22.
    Fong YC, Liu SC, Huang CY, Li TM, Hsu S-F, Kao S-T, et al. Osteopontin increases lung cancer cells migration via activation of the alpha v beta 3 integrin/FAK/Akt and NF-kappa B-dependent pathway. Lung Cancer. 2009;64:263–70.CrossRefGoogle Scholar
  23. 23.
    Zhou GL, Zhuo Y, King CC, Fryer BH, Bokoch GM, Field J. Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration. Mol Cell Biol. 2003;23:8058–69.CrossRefGoogle Scholar
  24. 24.
    Yang JX, Tang WL, Wang XX. Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy. 2010;12:251–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Jun Jin
    • 1
  • Guifu Zuo
    • 3
  • Guangyao Xiong
    • 2
  • Honglin Luo
    • 1
  • Qiuping Li
    • 2
  • Chunying Ma
    • 2
  • Deying Li
    • 2
  • Feng Gu
    • 4
  • Yongjie Ma
    • 5
  • Yizao Wan
    • 1
    Email author
  1. 1.Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and EngineeringTianjin UniversityTianjinPeople’s Republic of China
  2. 2.School of Mechanical and Electrical EngineeringEast China Jiaotong UniversityNanchangPeople’s Republic of China
  3. 3.Hebei Provincial Key Laboratory of Inorganic Nonmetallic Materials, College of Materials Science and EngineeringHebei United UniversityTangshanChina
  4. 4.Department of Breast Cancer Pathology, Cancer Institute and HospitalTianjin Medical UniversityTianjinPeople’s Republic of China
  5. 5.Department of Core Laboratory, Cancer Institute and HospitalTianjin Medical UniversityTianjinPeople’s Republic of China

Personalised recommendations